Shares outstanding increased 119.7%
Shares outstanding changed +119.7% from the comparable as-filed period. The change ranks at the 86th percentile of 7 prior comparable changes.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Shares outstanding changed +119.7% from the comparable as-filed period. The change ranks at the 86th percentile of 7 prior comparable changes.
Operating income changed -74.4% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Current ratio changed +658.6% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Working capital / assets changed +72747 basis points from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Research & development changed +114.4% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.